The current treatment process with CAR T cells – Penn Medicine
Penn Medicine, University of Pennsylvania Health System shared a post on LinkedIn:
“CAR T cells have cured cancer for many patients. But the current treatment process is a laborious (and expensive) one.
CAR T cell therapy pioneer Carl June, MD, has teamed up with Nobel Laureate Drew Weissman, MD, PhD, to explore the possibility of using mRNA vaccines to help a patient’s own body create the CAR T cells needed to train the immune system to fight cancer.”
Yan Leyfman, Co-founder and executive director of MedNews Week, shared this post, adding:
“An innovative approach to develop next-generation CAR T cells but questions remains about efficacy and safety. Nonetheless an exciting time for the field.”
Proceed to the video attached to the post.
More posts featuring Yan Leyfman.
Yan Leyfman MD, is the Co-founder and executive director of MedNews Week. He is also the Medical correspondent at OncLive.
He is also the Executive Committee Member at Music Beats Cancer. He is a Clinical Researcher at Icahn School of Medicine at Mount Sinai. His research interests include oncology, Immunooncology, Cellular Therapy, and Immunotherapy.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023